Harry W. Alcorn Jr., Chief Medical Officer at DiaMedica Therapeutics Inc. (DMAC), bought 1,000 shares at $4.00 ($4K) on 2018-12-11, disclosed to the SEC on 2018-12-11.
Open-market purchase of $4k DMAC by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| DMAC | BUY | 2019-08-16 | $19K | — | Filing → |
| DMAC | BUY | 2019-03-29 | $669 | — | Filing → |